Open original FDA record ↗Recall record
- FDA identifier
- Z-1328-2009
- Company in FDA record
- Nova Biomedical Corporation
- FDA classification date
- May 7, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Erroneous, low creatinine results on CCX analyzer
Source facts
- Action
- Initial: USA and Canada - Customer Advisory Notice notification by phone contact with key customer contact facilitated using a Field Correction Script. This contact will be documented within the Nova Biomedical Technical Support database (Pivotal) and on a Field Correction Checklist. All affected inventory will be replaced at customer sites. International - Customer Advisory Notice and Faxback Form being communicated and sent to Nova Biomedical Subsidiaries and Distributors by three methods of delivery (Email, Fax and Phone Call). Follow-up: USA and Canada - Sending the Customer Advisory Notice by email and/or fax to the key customer contact from the initial phone contact. International - Sending the Customer Advisory Notice by email and/or fax to the key contact.
- Initiated
- 2008-08-11
- Root cause
- Process control
- Terminated
- 2011-07-22
- Distribution
- Worldwide Distribution -- USA, Canada, Germany, France, Czech Republic, Taiwan, Japan, Thailand, Italy, Hungary, India, UK, Ireland, Venezuela, Brazil, and Hong Kong.
- Recall number
- Z-1328-2009
- Recall status
- Terminated
- CDRH record ID
- 72815
- FDA classified
- 2009-05-07
- Recall event number
- 49127